Benzinga | Sep 9, 2021 06:36AM EDT

Immuneering Q2 Sales $660.00K Up From $480.80K YoY

Immuneering (NASDAQ:IMRX) reported $660.00 thousand in sales this quarter. This is a 37.27 percent increase over sales of $480.80 thousand the same period last year.